Additionally, in certain cancer types like BRCA, CD300E shows a positive correlation with regulatory T cells (Tregs), which play a critical role in modulating the immune system, particularly in maintaining immune tolerance and suppressing excessive immune responses. Here, CD300E is linked to cancer.